Innovative Cellular Therapeutics Holdings Ltd
10% Owner at Lyell Immunopharma, Inc. (LYEL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $274
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 20SEC | LYELLyell Immunopharma, Inc. | Sell Plan | 102,857,480 held (−0%) | $13.70 | $137 | -40.7% |
| Jul 17SEC | LYELLyell Immunopharma, Inc. | Sell Plan | 102,857,490 held (−0%) | $13.73 | $137 | -40.9% |
- Sell
10% Owner Innovative Cellular Therapeutics Holdings Ltd sold $137 of LYEL at $13.70 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Innovative Cellular Therapeutics Holdings Ltd sold $137 of LYEL at $13.73 — pre-scheduled 10b5-1 plan sale.